SharePoint

Skip Navigation LinksLegal and Regulatory

Description
  

​Relaxed Regulations at the State and Federal level have helped behavioral health providers deliver services via telehealth. Here is an executive summary of these regualtions. 

06/20 Relaxed Regulations Executive Summary

Interpreter Services: The HCA has created this Apple Health (Medicaid) interpreter services policy during COVID-19 pandemic

Apple Health (Medicaid) interpreter services policy during COVID-19 pandemic

ABA Policy & Billing: Click here for Apple Health (Medicaid) Applied Behavior Analysis (ABA) policy and billing during the COVID-19 pandemic

Applied Behavioral Analysis (ABA) policy and billing

CMS emergencies webpage, which currently contains the latest information on Coronavirus Waivers & Flexibilities; guidance on clinical & technical, billing & coding, survey & certification, coverage, provider enrollment, Medicaid & CHIP, marketplace plan, MA plan, open payments, as well as partner & stakeholder resources and consumer information.

CMS Current Emergencies page

Opioid Treatment Program: The HCA created this COVID-19 and opioid treatment programs frequently asked questions.
It is meant to support opioid treatment program (OTP) medical directors relating to the corona virus (COVID-19) situation in Washington. This guidance contains recommendations and resources from
state and federal partners.​

HCA COVID-19 and Opioid Treatment Programs

​HCA’s Division of Behavioral Health and Recovery (DBHR) created this behavioral health provider COVID-19 information/guidance document, based on the questions presented during the weekly webinars and emails.

Check this document regularly because things change in a few hours with Federal and state government guidance.
HCA Weekly Update for Behavioral Health Providers

​HIPAA: This HHS webpage provides information on privacy rules during emergency situations.
There is a link to HHS Office for Civil Rights (OCR) guidance that helps explain civil rights laws as well as how the HIPAA Privacy Rule allows patient information to be shared in the outbreak of infectious disease and to assist patients in receiving the care they need.​

HHS waiving waive potential HIPAA penalties

​Confidentiality (42 CFR Part 2): ASAM has developed this summary of “Changes to 42 CFR Part 2 in the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020”

There is also a helpful compilation of Resources.
https://www.asam.org/advocacy/federal-advocacy/standardize-the-delivery-of-individualized-addiction-treatment/confidentiality-(42-cfr-part-2)-new

Signature Requirements: The HCA has developed these signature requirements for delivery of prescribed medications during COVID-19 pandemic

https://www.hca.wa.gov/assets/billers-and-providers/signature-requirements-pharmacy.pdf

​Buprenorphine: The HCA created this FAQ document for COVID-19 and prescribers of buprenorphine containing products in office based opioid treatment settings

It is meant to support prescribers of buprenorphine containing products in office based opioid treatment settings relating to the coronavirus (COVID-19) situation in Washington. This interim guidance contains recommendations and resources.

If you have additional questions, please email them to Washington State Opioid Treatment Authority Jessica Blosejessica.blose@hca.wa.gov.
Prescribers of buprenorphine containing products in office based opioid treatment settings